milrinone and alprostadil

milrinone has been researched along with alprostadil in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoffmann, A; Klöcking, HP1
Bonnet, PA; Chevillard, C; Michel, A; Vittet, D; Zurbonsen, K1
Heintz, B; Kirsten, D; Kirsten, R; Nelson, K1
Bivalacqua, TJ; Champion, HC; Doherty, PC; Hellstrom, WJ; Kadowitz, PJ; Rajasekaran, M; Sikka, SC1
Ikeda, T; Kazama, T; Kikura, M; Sato, S1
Awad, H; Michler, RE; Stobierska-Dzierzek, B1

Reviews

2 review(s) available for milrinone and alprostadil

ArticleYear
Clinical pharmacokinetics of vasodilators. Part II.
    Clinical pharmacokinetics, 1998, Volume: 35, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilol; Enoximone; Female; Humans; Iloprost; Imidazoles; Indoramin; Isosorbide Dinitrate; Labetalol; Milrinone; Molsidomine; Nitroglycerin; Nitroprusside; Oxyfedrine; Pentaerythritol Tetranitrate; Phosphodiesterase Inhibitors; Piperazines; Prazosin; Pregnancy; Propanolamines; Pyridones; Theophylline; Trapidil; Vasodilator Agents

1998
The evolving management of acute right-sided heart failure in cardiac transplant recipients.
    Journal of the American College of Cardiology, 2001, Volume: 38, Issue:4

    Topics: Alprostadil; Animals; Cardiotonic Agents; Epoprostenol; Heart Transplantation; Heart-Assist Devices; Hemodynamics; Humans; Hypertension, Pulmonary; Milrinone; Nitric Oxide; Phosphodiesterase Inhibitors; Risk Factors; Vasodilator Agents; Ventricular Dysfunction, Right

2001

Other Studies

4 other study(ies) available for milrinone and alprostadil

ArticleYear
Inhibition of thrombin-induced tissue-type plasminogen activator release by agents which increase intracellular cyclic AMP.
    Thrombosis research, 1990, Aug-15, Volume: 59, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Animals; Colforsin; Cyclic AMP; Ear, External; In Vitro Techniques; Milrinone; Perfusion; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Solutions; Swine; Thrombin; Tissue Plasminogen Activator

1990
Dissociation between phosphodiesterase inhibition and antiproliferative effects of phosphodiesterase inhibitors on the Dami cell line.
    Biochemical pharmacology, 1997, Apr-25, Volume: 53, Issue:8

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Alprostadil; Cell Division; Cyclic AMP; Humans; Isoenzymes; Isoquinolines; L-Lactate Dehydrogenase; Leukemia, Megakaryoblastic, Acute; Milrinone; Phosphodiesterase Inhibitors; Phthalazines; Pyridones; Pyrrolidinones; Rolipram; Tetrahydroisoquinolines; Tumor Cells, Cultured

1997
Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
    The Journal of urology, 1999, Volume: 162, Issue:5

    Topics: Alprostadil; Animals; Cats; Cells, Cultured; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Male; Milrinone; Penile Erection; Penis; Phosphodiesterase Inhibitors; Purinones; Rolipram

1999
Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
    Platelets, 2000, Volume: 11, Issue:8

    Topics: Adenosine Diphosphate; Adult; Alprostadil; Amrinone; Cardiotonic Agents; Collagen; Cyclic AMP; Dose-Response Relationship, Drug; Electrochemistry; Humans; Kinetics; Male; Middle Aged; Milrinone; Platelet Aggregation; Platelet Aggregation Inhibitors; Vasodilator Agents

2000